Bevacizumab for Central Retinal Vein Occlusion Study

Clinical trial NCT00906685 · COMPLETED

Trial details

NCT number: NCT00906685
Sponsor: Anders Kvanta
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Retinal Vein Occlusion

Start date: 2009-05-01
Primary completion: 2011-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.